scholarly article | Q13442814 |
P5530 | Altmetric DOI | 10.1053/J.GASTRO.2017.12.003 |
P6409 | CORE ID | 144581850 |
P6179 | Dimensions Publication ID | 1099660493 |
P356 | DOI | 10.1053/J.GASTRO.2017.12.003 |
P953 | full work available at URL | http://eprints.whiterose.ac.uk/125742/ |
P932 | PMC publication ID | 5880715 |
P698 | PubMed publication ID | 29247777 |
P1154 | Scopus EID | 2-s2.0-85044608490 |
P50 | author | Jesper Lagergren | Q5931193 |
Carlos Caldas | Q9696930 | ||
Leslie Bernstein | Q60607806 | ||
Paul D P Pharoah | Q61822938 | ||
Shanshan Zhao | Q61832423 | ||
Nicholas J. Shaheen | Q64749672 | ||
Anna H Wu | Q89864403 | ||
Marilie Gammon | Q104751082 | ||
Douglas A. Corley | Q110251065 | ||
Stomach and Oesophageal Cancer Study (SOCS) consortium | Q125294954 | ||
Matthew F Buas | Q38360951 | ||
Puya Gharahkhani | Q47502881 | ||
Laura J. Hardie | Q47944593 | ||
Bradley J Kendall | Q56449778 | ||
Weimin Ye | Q57055090 | ||
P2093 | author name string | Jing Dong | |
Geoffrey Liu | |||
David C Whiteman | |||
Wong-Ho Chow | |||
Harvey A Risch | |||
Rebecca C Fitzgerald | |||
Brian J Reid | |||
Lesley A Anderson | |||
Thomas L Vaughan | |||
Lynn Onstad | |||
Aaron P Thrift | |||
Prasad G Iyer | |||
Nigel C Bird | |||
P2860 | cites work | Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis | Q24602426 |
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus | Q28943522 | ||
Cancer statistics, 2016 | Q29547383 | ||
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. | Q30238753 | ||
Quality control and quality assurance in genotypic data for genome-wide association studies | Q30498925 | ||
A multibiomarker risk score helps predict risk for Barrett's esophagus | Q33779408 | ||
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial | Q33883502 | ||
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus | Q34298428 | ||
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study | Q34354158 | ||
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review | Q34487254 | ||
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
The epidemic of oesophageal carcinoma: Where are we now? | Q87241077 | ||
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis | Q34537405 | ||
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus | Q35042479 | ||
Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus. | Q35149279 | ||
Precision prevention of oesophageal adenocarcinoma | Q35243217 | ||
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium | Q36504770 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
A clinical risk prediction model for Barrett esophagus. | Q37114501 | ||
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux | Q37325010 | ||
Genomic prediction of coronary heart disease | Q37487395 | ||
Prediction of Barrett's esophagus among men. | Q37519245 | ||
Age at onset of GERD symptoms predicts risk of Barrett's esophagus | Q37678177 | ||
Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide | Q38193133 | ||
A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention | Q38921914 | ||
Prediction models need appropriate internal, internal-external, and external validation | Q39005870 | ||
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci | Q39326953 | ||
Risk assessment models for genetic risk predictors of lung cancer using two-stage replication for Asian and European populations | Q40040989 | ||
External Validation of the Michigan Barrett's Esophagus Prediction Tool. | Q40289642 | ||
A review of goodness of fit statistics for use in the development of logistic regression models | Q40338804 | ||
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q42952638 | ||
A model to determine absolute risk for esophageal adenocarcinoma. | Q46881635 | ||
The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends | Q47322343 | ||
Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few Validated | Q48038405 | ||
Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study. | Q48874889 | ||
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. | Q50875389 | ||
Barrett's oesophagus | Q54290278 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
Barrett's esophagus | Q808892 | ||
P577 | publication date | 2017-12-13 | |
P1433 | published in | Gastroenterology | Q4039279 |
P1476 | title | Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants |
Q95488201 | Barrett oesophagus |
Q54232649 | Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really? |
Q96953242 | Flaming the fight against cancer cells: the role of microRNA-93 |
Q92505682 | Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984-2013 |
Q89113888 | Natural History of Barrett's Esophagus |
Q92968472 | Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis |
Q92885531 | Synthetic circular multi-miR sponge simultaneously inhibits miR-21 and miR-93 in esophageal carcinoma |
Q60960098 | The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy |
Search more.